Our Future
Every major leap in medicine began with people who believed in a better future.
Niclosavir is bridging the gap between research and mainstream.
To drive large-scale adoption of our technology, we need a strategic investment plan that bridges the critical gap between research & development and real-world implementation.
• Robust Intellectual Property Strategy
Veterinary applications
Medical applications
Broaden our global patent portfolio, ensuring our technologies are protected across key markets.
Build the infrastructure and attract the talent needed to scale our solutions globally.
Establish Niclosavir as a world leader in reducing the use of antibiotics in both animals and humans.
Continue to invest in and complete new feasibility studies, unlocking the full potential of the NicTek platform.
• Further Applications
Medical Applications
An anti-microbial formulation for use in the treatment of trauma tic wounds and ulcers.
A topical application.
Veterinary Applications
A dual-action formulation that is species specific
A disease-specific and species-specific formulation for use in lactating dairy mammals.